Diana Cervantes-Madrid

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2019
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Endoplasmic Reticulum Stress

Epidermal Growth Factor Receptor

Top Venues

Science signaling

Scientific reports

University of Gothenburg

Instituto Nacional de Cancerologia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Gothenburg

Sweden

Researcher :: Dep. of Medical Biochemistry and Cell Biology

University of Gothenburg

Sweden

Postdoctoral fellow :: Dep. of Medical Biochemistry and Cell Biology

Education History

Instituto Nacional de Cancerologia Aug 01 2010 - Aug 18 2015

Mexico

PHD :: Basic Research (Epigenetics)

Publications

Diana Cervantes-Madrid, Joanna Szydzik, Dan Emil Lind, Marcus Borenäs, Mats Bemark, Jean Cui, Ruth Helen Palmer, Bengt Hallberg
Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells. Scientific reports 9 (1) (2019)
Jimmy Van den Eynden, Ganesh Umapathy, Arghavan Ashouri, Diana Cervantes-Madrid, Joanna Szydzik, Kristina Ruuth, Jan Koster, Erik Larsson, Jikui Guan, Ruth H Palmer, Bengt Hallberg
Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways. Science signaling 11 (557) (2018)
Ganesh Umapathy, Jikui Guan, Dan Emil Lind, Niloufar Javanmardi, Diana Cervantes-Madrid, Anna Djos, Tommy Martinsson, Ruth H Palmer, Bengt Hallberg
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas. Science signaling 10 (507) (2017)